The Role of 18F-AlF-NOTA-Octreotide PET/CT in the Evaluation of Central Nervous System Metastases in Neuroblastoma
18 F-AlF-NOTA-octreotide PET/CT demonstrates exceptional diagnostic sensitivity for detecting CNS metastases in NB, serving as a valuable complementary imaging modality.
Authors
- Jun Liu (ORCID: https://orcid.org/0000-0002-1907-8989)
- Jigang Yang (ORCID: https://orcid.org/0000-0002-0538-7676)
- Siqi Li (ORCID: https://orcid.org/0000-0002-4569-1111)
- Han Wang (ORCID: https://orcid.org/0000-0001-8042-1232)
- Yuxuan Liu (ORCID: https://orcid.org/0000-0003-4426-9290)
- Xiaorong Sun (ORCID: https://orcid.org/0000-0001-8520-9556)
- Yanfeng Xu (ORCID: https://orcid.org/0000-0003-0947-7254)
Institutions
- Capital Medical University (CN)
- Shandong Tumor Hospital (CN)
- Beijing Friendship Hospital (CN)
- Shandong First Medical University (CN)
- Dazhou Central Hospital (CN)
Publication Details
- Journal
- Clinical Nuclear Medicine
- Published
- 2025-07-30
- DOI
- https://doi.org/10.1097/rlu.0000000000006073
- Citations
- 4
- Primary Topic
- Neuroblastoma Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 5.56